Alan Levy, MD
Dermatology · Memphis, TNNPI 1497978340
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,102 of the $9,735 with a category attached, or 72.9%. 31 manufacturers reported payments, led by AbbVie at 47.0% of the total. Reporting peaked in 2019 at $4,147 and has fallen 78.0% since, to $914 in 2025.
Across 383 payments — averaging $25.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Galderma Laboratories, L.p.$695
- Pfizer$658
- Merz North America, Inc.$580
- Johnson & Johnson$511
- Novartis$497
- plus $2K from 25 others
What the payments were for
- Speaking & faculty fees$2,45025%
- Food & beverage$7,10273%
- Education$1832%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 165 | $4,578 |
| Galderma Laboratories, L.p. | 24 | $695 |
| Pfizer | 32 | $658 |
| Merz North America, Inc. | 4 | $580 |
| Johnson & Johnson | 21 | $511 |
| Novartis | 26 | $497 |
| Sanofi | 20 | $430 |
| E.r. Squibb & Sons, L.L.C. | 15 | $269 |
| LEO Pharma Inc. | 9 | $191 |
| Lilly USA, LLC | 10 | $180 |
| Sun Pharmaceutical Industries Inc. | 6 | $144 |
| Mayne Pharma Commercial LLC | 7 | $142 |
| Kerecis Limited | 3 | $103 |
| Regeneron Healthcare Solutions, Inc. | 5 | $97 |
| Almirall LLC | 4 | $84 |
| Revance Therapeutics, Inc. | 2 | $75 |
| Genentech USA, Inc. | 4 | $54 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $53 |
| Convatec Inc. | 2 | $48 |
| Arcutis Biotherapeutics, Inc. | 3 | $47 |
| Dermavant Sciences, Inc. | 3 | $45 |
| Botanix SB Inc | 1 | $39 |
| Organogenesis Inc. | 2 | $38 |
| Incyte Corporation | 2 | $34 |
| Journey Medical Corporation | 2 | $25 |
| VYNE Pharmaceuticals Inc. | 1 | $24 |
| Merck | 2 | $23 |
| Amgen | 1 | $23 |
| UCB, Inc. | 1 | $19 |
| Biofrontera Inc. | 1 | $19 |
| Strata Skin Sciences, Inc. | 2 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,735 in reported general payments places this provider in the 75th percentile of 209 dermatology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 50 | $227 |
| Mupirocin | 19 | $165 |
| Doxycycline Hyclate | 17 | $163 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $66 |
| Amoxicillin | 25 | $15 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Memphis
- Emily OverholserMemphis$322K
- Sarah SmithMemphis$80K
- Robert KaplanMemphis$9K
- Kimberly VincentNashville$1.5M
- Adrian RodriguezNashville$1.1M
- Michael GoldNashville$748K
- Joni SagoKingsport$661K
- Jennifer LeeBrentwood$396K
- Christina FeserClarksville$383K
- James TurnerBartlett$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.